$PHIO·4

RXi Pharmaceuticals Corp · Feb 3, 5:16 PM ET

RXi Pharmaceuticals Corp 4

4 · RXi Pharmaceuticals Corp · Filed Feb 3, 2017

Insider Transaction Report

Form 4
Period: 2017-02-01
Kontulis Caitlin
Secretary & Controller
Transactions
  • Award

    Stock option (right to buy)

    2017-02-01+2,5002,500 total
    Exercise: $0.63Exp: 2027-02-01Common Stock (2,500 underlying)
Footnotes (1)
  • [F1]The stock option vests 12.5% on the six month anniversary of the grant date, 12.5% on the one year anniversary of the grant date, and 25% on each of the second, third, and fourth anniversaries of the grant date thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION